You just read:

Regeneron and Sanofi Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine

News provided by

Regeneron Pharmaceuticals, Inc.

Mar 15, 2015, 11:00 ET